• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主要组织相容性复合体II类分子介导的内源性抗原呈递。

Endogenous antigen presentation by MHC class II molecules.

作者信息

Sant A J

机构信息

Department of Pathology, University of Chicago, IL 60637, USA.

出版信息

Immunol Res. 1994;13(4):253-67. doi: 10.1007/BF02935617.

DOI:10.1007/BF02935617
PMID:7616053
Abstract

T cell recognition of antigen requires that a complex form between peptides derived from the protein antigen and cell surface glycoproteins encoded by genes within the major histocompatibility complex (MHC). MHC class II molecules present both extracellular (exogenous) and internally synthesized (endogenous) antigens to the CD4 T cells subset of lymphocytes. The mechanisms of endogenous antigen presentation are the subject of this review. Isolation and amino acid sequencing of peptides bound to the class II molecule indicate that a very high proportion (70-90%) of the total peptides presented by the class II molecule are in fact derived from the pool of proteins that are synthetized within the antigen-presenting cell (APC). This type of sequence information as well as the study of model antigens has indicated that proteins expressed in a diversity of intracellular sites, including the cell surface, endoplasmic reticulum and cytosol can gain access to the class II molecule, albeit with different efficiencies. The main questions that remain to be answered are the intracellular trafficking patterns that allow colocalization of internally synthesized antigens with the class II molecule, the site(s) within the cell where peptide:class II molecule complex formation can take place and whether presentation of 'foreign' as well as 'self' antigens takes place by mechanisms that vary from one cell type to another or that vary with the metabolic state of the APC. If such variability exists, is would imply that the array of peptides displayed by class II molecules at the cell surface has similar variability, a possibility that would impact on self tolerance and autoimmunity.

摘要

T细胞对抗原的识别要求蛋白质抗原衍生的肽与主要组织相容性复合体(MHC)内基因编码的细胞表面糖蛋白之间形成复合物。MHC II类分子将细胞外(外源性)和内源性合成的抗原呈递给淋巴细胞的CD4 T细胞亚群。内源性抗原呈递的机制是本综述的主题。与II类分子结合的肽的分离和氨基酸测序表明,II类分子呈递的总肽中很大一部分(70-90%)实际上来自抗原呈递细胞(APC)内合成的蛋白质库。这种类型的序列信息以及对模型抗原的研究表明,在包括细胞表面、内质网和细胞质在内的多种细胞内位点表达的蛋白质都可以与II类分子结合,尽管效率不同。仍有待回答的主要问题是允许内源性合成抗原与II类分子共定位的细胞内运输模式、细胞内肽:II类分子复合物形成的位点,以及“外来”和“自身”抗原的呈递是否通过因细胞类型而异或因APC代谢状态而异的机制进行。如果存在这种变异性,这将意味着II类分子在细胞表面展示的肽阵列具有类似的变异性,这种可能性将影响自身耐受性和自身免疫性。

相似文献

1
Endogenous antigen presentation by MHC class II molecules.主要组织相容性复合体II类分子介导的内源性抗原呈递。
Immunol Res. 1994;13(4):253-67. doi: 10.1007/BF02935617.
2
Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.人巨细胞病毒糖蛋白US3对HLA-DR组装、运输和负载的抑制作用:逃避主要组织相容性复合体II类抗原呈递的新机制
J Virol. 2002 Nov;76(21):10929-41. doi: 10.1128/jvi.76.21.10929-10941.2002.
3
Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.用于体内诱导CD4+T细胞耐受性的自身肽的呈递受一个定位在主要组织相容性复合体基因座II类区域的加工因子调控。
J Exp Med. 1995 Nov 1;182(5):1481-91. doi: 10.1084/jem.182.5.1481.
4
LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.LAMP-2 缺陷型人 B 细胞对外源抗原的 MHC Ⅱ类呈递发生改变。
Immunology. 2010 Nov;131(3):318-30. doi: 10.1111/j.1365-2567.2010.03309.x.
5
Endogenous pathway of class II presentation.II类分子提呈的内源性途径
Biochem Soc Trans. 1995 Aug;23(3):657-60. doi: 10.1042/bst0230657.
6
Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.MHC II类癌症疫苗对内源性合成的MHC II类限制性表位的呈递不依赖于与抗原加工相关的转运体和蛋白酶体。
J Immunol. 2005 Feb 15;174(4):1811-9. doi: 10.4049/jimmunol.174.4.1811.
7
Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex A alpha A beta dimers from the endoplasmic reticulum/cis-Golgi compartment.恒定链促进低表达、单倍型不匹配的II类主要组织相容性复合体AαAβ二聚体从内质网/顺式高尔基体区室的流出。
Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2346-50. doi: 10.1073/pnas.88.6.2346.
8
Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.将内源性抗原引入主要组织相容性复合体(MHC)II类呈递途径。Ii介导的对内源性肽/MHC II类呈递的抑制和增强都需要相同的Ii结构域。
Immunology. 2001 Apr;102(4):405-15. doi: 10.1046/j.1365-2567.2001.01208.x.
9
The ins and outs of MHC class II-mediated antigen processing and presentation.MHC II类分子介导的抗原加工与呈递的来龙去脉。
Nat Rev Immunol. 2015 Apr;15(4):203-16. doi: 10.1038/nri3818. Epub 2015 Feb 27.
10
Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.单纯疱疹病毒1型靶向主要组织相容性复合体II类加工途径以逃避免疫。
J Immunol. 2003 Sep 15;171(6):3075-83. doi: 10.4049/jimmunol.171.6.3075.

引用本文的文献

1
T-cell receptor insights: Determinants of Major Histocompatibility Complex class I versus class II recognition.T细胞受体见解:主要组织相容性复合体I类与II类识别的决定因素
Protein Sci. 2025 Sep;34(9):e70262. doi: 10.1002/pro.70262.
2
β-Glucan induced plasma B cells differentiation to enhance antitumor immune responses by Dectin-1.β-葡聚糖通过Dectin-1诱导血浆B细胞分化以增强抗肿瘤免疫反应。
BMC Immunol. 2025 Jan 10;26(1):2. doi: 10.1186/s12865-025-00681-z.
3
Innate and adaptive immune responses toward nanomedicines.针对纳米药物的先天性和适应性免疫反应。

本文引用的文献

1
Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.来自被隔离在抗原呈递细胞细胞质或内质网中的内源性抗原的鸡卵溶菌酶决定簇的II类限制性呈递。
J Immunol. 1993 May 1;150(9):3690-7.
2
Invariant chain retains MHC class II molecules in the endocytic pathway.恒定链在内吞途径中保留MHC II类分子。
J Immunol. 1993 Apr 15;150(8 Pt 1):3187-97.
3
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
Acta Pharm Sin B. 2021 Apr;11(4):852-870. doi: 10.1016/j.apsb.2021.02.022. Epub 2021 Mar 13.
4
Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen.人白细胞介素-4和干扰素-α诱导的单核细胞来源树突状细胞对游离抗原与细胞相关抗原交叉呈递的差异能力。
Cancer Immunol Immunother. 2015 Nov;64(11):1419-27. doi: 10.1007/s00262-015-1741-1. Epub 2015 Jul 28.
5
The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection.当前可用于预测病原体感染后 CD4 T 细胞识别的肽段的网络算法的实用性和局限性。
J Immunol. 2012 May 1;188(9):4235-48. doi: 10.4049/jimmunol.1103640. Epub 2012 Mar 30.
6
Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation.流感 A 病毒诱导功能性巨自噬,但对主要组织相容性复合体 II 类限制呈递无贡献。
J Virol. 2011 Jul;85(13):6453-63. doi: 10.1128/JVI.02122-10. Epub 2011 Apr 27.
7
Urothelial antigen-specific CD4+ T cells function as direct effector cells and induce bladder autoimmune inflammation independent of CD8+ T cells.尿路上皮抗原特异性 CD4+ T 细胞作为直接效应细胞,在不依赖 CD8+ T 细胞的情况下诱导膀胱自身免疫炎症。
Mucosal Immunol. 2011 Jul;4(4):428-37. doi: 10.1038/mi.2010.90. Epub 2011 Jan 26.
8
Recipient B cells are not required for graft-versus-host disease induction.受者 B 细胞对于移植物抗宿主病的诱导不是必需的。
Biol Blood Marrow Transplant. 2010 Sep;16(9):1222-30. doi: 10.1016/j.bbmt.2010.03.015. Epub 2010 Mar 23.
9
Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.用人源甲型流感病毒(H1N1)分离株感染HLA - DR1转基因小鼠,可引发多样的CD4 T细胞库,其中包括对禽源(H5N1)流感病毒具有异源亚型交叉反应性的CD4 T细胞。
J Virol. 2009 Jul;83(13):6566-77. doi: 10.1128/JVI.00302-09. Epub 2009 Apr 22.
10
Understanding the focused CD4 T cell response to antigen and pathogenic organisms.理解针对抗原和病原体的聚焦 CD4 T 细胞反应。
Immunol Res. 2009 Dec;45(2-3):123-43. doi: 10.1007/s12026-009-8095-8. Epub 2009 Feb 7.
人类II类组织相容性抗原HLA - DR1的三维结构。
Nature. 1993 Jul 1;364(6432):33-9. doi: 10.1038/364033a0.
4
Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways.主要组织相容性复合体II类分子对内部合成抗原的递呈表现出细胞类型变异性,并与外源性II类分子和内源性I类分子递呈途径相分离。
J Exp Med. 1993 Jul 1;178(1):73-85. doi: 10.1084/jem.178.1.73.
5
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.与HLA - DR等位基因结合的天然加工肽之间的特异性和混杂性。
J Exp Med. 1993 Jul 1;178(1):27-47. doi: 10.1084/jem.178.1.27.
6
Delineation of the subunit composition of human proteasomes using antisera against the major histocompatibility complex-encoded LMP2 and LMP7 subunits.利用针对主要组织相容性复合体编码的LMP2和LMP7亚基的抗血清描绘人类蛋白酶体的亚基组成。
Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):296-300. doi: 10.1073/pnas.91.1.296.
7
Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents.主要组织相容性复合体II类限制性呈递分泌型和内质网驻留抗原需要恒定链,且对溶酶体促渗剂敏感。
Eur J Immunol. 1993 Dec;23(12):3167-72. doi: 10.1002/eji.1830231219.
8
Isolation and characterization of the intracellular MHC class II compartment.细胞内MHC II类区室的分离与鉴定。
Nature. 1994 May 12;369(6476):120-6. doi: 10.1038/369120a0.
9
Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes.新的II类主要组织相容性复合体分子在B淋巴细胞的一个新型内吞区室中的短暂积累。
Nature. 1994 May 12;369(6476):113-20. doi: 10.1038/369113a0.
10
MHC class II antigen processing: biology of invariant chain.MHC II类抗原加工:恒定链的生物学特性
Curr Opin Immunol. 1994 Feb;6(1):57-63. doi: 10.1016/0952-7915(94)90034-5.